Gene Name	Entrez ID	Drug Name	Chembl ID	Interaction Types	Sources	publications

Gene Name	Variant	Alleles	Chemical	Phenotype Category	Significance	Notes	Sentence	Publications	Annotation ID
KLRC1	rs7301582	CC	adalimumab	efficacy	yes	Response measured 12 weeks after initiation of therapy.	Genotype CC is associated with decreased response to adalimumab, certolizumab pegol, etanercept, glucocorticoids, infliximab or methotrexate in people with Arthritis, Rheumatoid as compared to genotypes CT + TT.	26453102	1448266567
KLRC1	rs2734414	TT	adalimumab	efficacy	no	Response measured 12 weeks after initiation of therapy.	Genotype TT is not associated with response to adalimumab, certolizumab pegol, etanercept, glucocorticoids, infliximab or methotrexate in people with Arthritis, Rheumatoid as compared to genotypes AA + AT.	26453102	1448266578
KLRC1	rs2734440	TT	adalimumab	efficacy	no	Response measured 12 weeks after initiation of therapy.	Genotype TT is not associated with response to adalimumab, certolizumab pegol, etanercept, glucocorticoids, infliximab or methotrexate in people with Arthritis, Rheumatoid as compared to genotypes CC + CT.	26453102	1448266589